Executive Director, Clinical Development (MD)

Scorpion Therapeutics; Parsippany-Troy Hills (NJ); Hybrid; USD 250,000 - 450,000; Full time

Job summary

Scorpion Therapeutics seeks an Executive Director of Clinical Development (MD) to lead cell therapy programs focused on multiple myeloma. The role directs trial design, data analyses, regulatory tasks, and scientific communications, while representing products in cross-functional committees.

Ideal candidates hold an MD/DO with 8+ years in drug development, oncology and cellular therapy, with Phases 2-3 and GxP/ICH familiarity; board certification and prior leadership in cell therapy are

Qualifications

• MD/DO with 8+ years in clinical drug development, biopharma, oncology and cellular therapy.
• Familiarity with late-phase (Phases 2-3) studies and regulatory standards (GxP, ICH).
• Board certification in hematology/medical oncology preferred.

Responsibilities

• Direct clinical trial design, data analysis, regulatory documentation and scientific communications.
• Represent products in cross-functional committees.
• Lead or oversee clinical monitoring, study reporting and external scientific engagement.
• Develop external relationships and support business evaluations.

Skills

Clinical development

Regulatory strategy

Data analysis

Cross-functional leadership

Cell therapy

Education

MD/DO

Tools

GxP knowledge

ICH guidelines

Job description

Role:

Executive Director, Clinical Development (MD), specializing in multiple myeloma, leading cell therapy programs.

Responsibilities:

• direct clinical trial design, data analysis, regulatory documentation, and scientific communications
• represent products in cross-functional committees
• lead or oversee clinical monitoring, study reporting, and external scientific engagement
• develop external relationships and support business evaluations

Requirements:

MD/DO with 8+ years in clinical/scientific drug development, with experience in biopharma, oncology, and cellular therapy; familiarity with late-phase (Phases 2-3) studies and regulatory standards (GxP, ICH).

Preferred:

board certification in hematology/medical oncology, prior leadership in cell therapy, multiple myeloma expertise, and experience managing cross-functional teams and budgets.

High-Value:

focus on cell therapy, multiple myeloma, late-stage clinical trials, regulatory interactions, and external scientific representation.

Work setup:

location flexibility with travel as needed.